[DISCLOSURE] EuBiologics (206650) announced on April 17 that it has signed a 13.48 billion won (US$12.66 million) contract with UNICEF to supply oral cholera vaccine Euvichol Plus.
This amounts to 116.5 percent of its 2017 revenue and the contract is valid until Dec. 31.
